A method for preparing silk fibroin-based ultrafine monofilament sutures

By wet-stretching and chitosan coating of silk fibroin/polyvinyl alcohol/silk fibroin nanofiber composite fibers, the prepared ultrafine monofilament sutures solved the problems of insufficient strength and easy infection, and achieved high strength, antibacterial and healing-promoting effects.

CN118161647BActive Publication Date: 2026-11-17SUZHOU UNIV
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202410278624.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-12
Publication Date
2026-11-17
Estimated Expiration
2044-03-12

AI Technical Summary

Technical Problem

Existing monofilament sutures have low strength, posing a risk of wound dehiscence and easily causing inflammation and infection.

Method used

Antibacterial ultrafine monofilament sutures were prepared by wet-stretching of nascent composite fibers made of silk fibroin/polyvinyl alcohol/silk fibroin nanofibers and coating the fiber surface with chitosan.

Benefits of technology

The prepared sutures have a smooth surface and uniform structure, meet the requirements for suture strength, have antibacterial properties, reduce wound infection and scar formation, and promote wound healing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118161647B_ABST
    Figure CN118161647B_ABST
Patent Text Reader

Abstract

This invention discloses a method for preparing a silk fibroin-based ultrafine monofilament suture. The method involves stretching a composite fiber of silk fibroin / polyvinyl alcohol / silk fibroin nanofibers to obtain ultrafine fibers, and then coating the surface of the ultrafine fibers with chitosan to prepare the ultrafine monofilament suture. The suture has a smooth surface, uniform structure, a diameter of 36.6–42.9 μm, and a tensile strength of 0.25–0.31 N, meeting the strength requirements for suturing. It also exhibits good antibacterial properties, effectively inhibiting bacterial growth and reducing wound infection. Furthermore, the silk fibroin, polyvinyl alcohol, and chitosan used in this suture all possess excellent biocompatibility, promoting wound healing and reducing scar hyperplasia, demonstrating significant application potential in the field of medical suture materials.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biomedical materials technology and relates to a method for preparing a silk fibroin-based ultrafine monofilament suture. Background Technology

[0002] Surgical sutures are medical materials used in surgery to suture wounds and connect tissues; they are also the most common implantable materials in the human body. Different types of sutures are selected based on the size of the wound and the location of the suture. Each type of suture differs in diameter, toughness, strength, and the damage and tissue reaction caused by penetrating tissue. Larger diameter sutures have higher tensile strength and are easier to handle, but they are more likely to cause tissue inflammation and rejection reactions, and are more prone to scarring. They are suitable for large wounds and areas requiring high strength, such as suturing the skin of the trunk and limbs. Smaller diameter sutures cause less tissue damage, less capillary action, and faster wound healing, but require more precise suturing techniques. They are suitable for small wounds and areas requiring less strength, such as suturing the eyes, mouth, blood vessels, and organs. In general, given the required strength for wound closure, smaller diameter sutures are the superior choice in surgery.

[0003] Silk, a natural protein fiber, is rich in various amino acids such as glycine, alanine, and serine. It possesses excellent mechanical properties, biocompatibility, and low immunogenicity, making it one of the most important suture materials both domestically and internationally. Medical silk sutures exhibit superior moisture absorption, softness, and knot stability, and are widely used in wound closure, tissue fixation, and vascular ligation surgeries. Based on their preparation methods, they can be mainly classified into twisted sutures, braided sutures, barbed sutures, and monofilament sutures. In patent CN101244288A, the inventors disclosed a method for preparing a twisted silk surgical suture. This suture has a simple preparation process, a smooth surface, and high strength, but its shaping effect is unstable and it is prone to twisting and deformation during use. In patent CN103816564A, the inventors disclosed a method for preparing a braided silk suture. This suture is easy to operate, easy to knot, and has a stable structure that is not easily deformed. However, the suture diameter is large, and there are many gaps on the surface, which can easily hide bacteria and increase the risk of postoperative surgical wound infection. In patent CN113197705A, the inventors disclosed a method for preparing a barbed silk suture. This suture is simple to operate and does not require knotting, but the barb formation process is immature, the overall strength of the suture is uneven, and there is a risk of breakage during and after surgery. Compared with the three types of sutures mentioned above, monofilament sutures have a smooth surface, small diameter, and weak frictional resistance when penetrating tissue. They can effectively avoid large wounds, reduce pain, alleviate inflammation, avoid the risk of wound infection, and are less likely to cause scars and subcutaneous lumps. However, monofilament sutures have relatively low strength and pose a risk of wound dehiscence.

[0004] Therefore, how to develop a smooth, uniform, strong, biodegradable ultrafine monofilament suture is a problem that needs to be solved. Summary of the Invention

[0005] The purpose of this invention is to provide a method for preparing silk fibroin-based ultrafine monofilament sutures, which solves the problems of relatively low strength and potential wound dehiscence of existing monofilament sutures.

[0006] The technical solution of this invention is:

[0007] A method for preparing a silk fibroin-based ultrafine monofilament suture includes the following steps:

[0008] (1) The silk fibroin / polyvinyl alcohol / silk nanofiber nascent composite fiber is unwound from the winding roller and stretched and immersed in the bath liquid to moisten and soften it. Then it is pulled out of the bath liquid, enters the stretching device through the yarn guiding device, and is stretched between the two rollers of the stretching device. Finally, under the guidance of the reciprocating yarn guiding device, it is evenly wound onto the collecting device to obtain the stretched fiber.

[0009] (2) Using deionized water as a solvent, weigh chitosan powder and dissolve it in ascorbic acid solution to prepare chitosan solution. Fix both ends of the stretched fiber and immerse it completely in the chitosan solution. Take out the immersed fiber and dry it in a vacuum oven to obtain silk fibroin-based ultrafine monofilament suture.

[0010] Furthermore, in step (1), the preparation method of the silk fibroin / polyvinyl alcohol / silk fibroin nanofiber nascent composite fiber includes the following steps:

[0011] (1.1) Waste silkworm silk was boiled in a 0.25 wt.% sodium carbonate aqueous solution at a bath ratio of 1:400 for 25 minutes, and stirred appropriately to fully degummed the silkworm silk. The degummed waste silkworm silk was placed in a 9.3 mol / L lithium bromide aqueous solution and dissolved at 60°C at a mass ratio of 1:10. After dialysis, centrifugation, impurity removal and concentration, a 20 wt.% silk fibroin aqueous solution was obtained.

[0012] (1.2) The degummed waste silk is cut into short fibers of 5 mm in length, soaked in deionized water at a mass ratio of 1:100, mechanically ground for 30 to 90 minutes, and then the silk fibroin slurry is filtered through a 100 to 500 mesh filter, centrifuged, and filtered a second time to finally obtain a silk fibroin nanofiber aqueous solution with a concentration of 1 wt.%. The silk fibroin nanofiber aqueous solution has a length distribution range of 10 to 150 μm and a diameter distribution range of 20 to 250 nm.

[0013] (1.3) The silk fibroin nanofibers were added to the silk fibroin aqueous solution at an addition rate of 0.1 to 0.4 wt.%, and ultrasonically treated to disperse them evenly. The ultrasonic treatment time was 20 min, the temperature was 5℃, and the power was 120 W. A 20 wt.% polyvinyl alcohol aqueous solution was added to the ultrasonicated solution. The mass ratio of polyvinyl alcohol to silk fibroin was 1:1. After stirring evenly, a silk fibroin / polyvinyl alcohol / silk fibroin nanofiber composite aqueous solution was obtained. The silk fibroin / polyvinyl alcohol / silk fibroin nanofiber nascent composite fiber was prepared by dry-jet wet spinning method. The feed speed of the dry-jet wet spinning method was 2.8 ml / h, the inner diameter of the needle used for extrusion was 0.21 mm, the distance of the air section was 2 cm, the length of the coagulation bath was 90 cm, and the winding speed of the winding device was 92.3 m / h.

[0014] Furthermore, in step (1), the bath liquid is an ethanol solution with a concentration of 50 wt.% and the soaking time is 30-60 s.

[0015] Furthermore, in step (1), when the silk fibroin / polyvinyl alcohol / silk nanofiber nascent composite fiber is uniformly wound onto the collecting device under the guidance of the reciprocating yarn guiding device, it is necessary to adjust the fiber unwinding speed and the final collecting speed so that the draw ratio is 130-200%.

[0016] Furthermore, in step (2), the concentration of the ascorbic acid solution is 1 wt.%.

[0017] Furthermore, in step (2), the chitosan viscosity of the chitosan powder is ≥400mPa·s.

[0018] Furthermore, in step (2), the concentration of the chitosan solution is 0.5–3 wt.%.

[0019] Furthermore, in step (2), the soaking time is 1 to 5 minutes and the number of soakings is 1 to 5 times.

[0020] Furthermore, in step (2), the drying temperature is 60°C and the time is 3 minutes.

[0021] Furthermore, in step (2), the diameter of the silk fibroin-based ultrafine monofilament suture is 36.6–42.9 μm and the breaking strength is 0.25–0.31 N.

[0022] This invention provides a method for preparing silk fibroin-based ultrafine monofilament sutures. The method involves wet-processing and subsequent chitosan coating of nascent silk fibroin / polyvinyl alcohol / silk nanofiber composite fibers to obtain antibacterial ultrafine monofilament sutures. The fibers prepared by this method meet the requirements of the national standard YY0167-2020 for non-absorbable surgical sutures (size 9-0). In practical applications, compared to conventional surgical sutures, it can reduce the suture area, alleviate pain, decrease inflammation, promote wound healing, and reduce scar hyperplasia. It is particularly suitable for delicate suturing of tissues such as the face, eyes, and mouth. Attached Figure Description

[0023] Figure 1 The diagram shows the changes in the distribution of silk fibroin nanofibers inside the silk fibroin / polyvinyl alcohol / silk nanofiber nascent composite fiber before and after stretching treatment in Example 1 of the preparation method of silk fibroin-based ultrafine monofilament sutures according to the present invention. (a) is before stretching and (b) is after stretching.

[0024] Figure 2 The images show the surface morphology of the silk fibroin-based ultrafine monofilament suture prepared in Example 1 of the preparation method of the silk fibroin-based ultrafine monofilament suture according to the present invention before and after coating treatment, where (a) is before coating treatment and (b) is after coating treatment.

[0025] Figure 3 The image shows the antibacterial effect of the silk fibroin-based ultrafine monofilament suture prepared in Example 1 of the preparation method of the silk fibroin-based ultrafine monofilament suture according to the present invention against Escherichia coli and Staphylococcus aureus, wherein (a) represents Escherichia coli and (b) represents Staphylococcus aureus.

[0026] Figure 4 The diagram shows the in vitro degradation of the silk fibroin-based ultrafine monofilament suture prepared in Example 1 of the preparation method of the silk fibroin-based ultrafine monofilament suture according to the present invention in PBS simulated body fluid, where (a) is 5 days, (b) is 10 days, (c) is 15 days, (d) is 20 days, (e) is 25 days, and (f) is 30 days.

[0027] Figure 5 The silk fibroin-based ultrafine monofilament suture prepared in Example 1 according to the preparation method of the present invention is used for suturing mouse epidermis. In the figure, (a) is the immediate effect after suturing, (b) is the recovery after 5 days, (c) is the recovery after 10 days, and (d) is the recovery after 15 days. Detailed Implementation

[0028] The purpose of this invention is to provide a method for preparing silk fibroin-based ultrafine monofilament sutures. The method involves stretching and treating a flexible, high-elongation-at-break silk fibroin / polyvinyl alcohol / silk fibroin nanofiber composite fiber to obtain ultrafine fibers. Chitosan is then coated onto the surface of these ultrafine fibers to prepare the ultrafine monofilament sutures. Sutures treated only with stretching have a rough surface; if used directly for suturing, this results in significant friction between the suture and tissue, and bacteria can easily hide in the surface grooves. Therefore, chitosan, which has good film-forming properties, is selected for the coating treatment. Furthermore, chitosan can additionally impart certain antibacterial functions to the suture.

[0029] The specific steps are as follows:

[0030] (1) The nascent composite fibers of silk fibroin / polyvinyl alcohol / silk nanofibers are unwound from the winding roller and drawn into a 50 wt.% ethanol solution to soften them. After 30-60 seconds of immersion, they are drawn out of the bath and enter the drawing device through the yarn guide device. They are then drawn between two rollers in the drawing device. Finally, under the guidance of the reciprocating yarn guide device, they are evenly wound onto the collecting device. The fiber unwinding speed and the final collecting speed are controlled. When the draw ratio is less than 130%, the average fiber diameter is relatively large, about 45 μm, which exceeds the requirements of the national standard 9-0 thread. When the draw ratio is greater than 200%, the fibers are prone to breakage during actual operation, making continuous drawing difficult. Therefore, a more suitable draw ratio is 130-200%.

[0031] The preparation method of the silk fibroin / polyvinyl alcohol / silk fibroin nanofiber composite fiber mentioned in the above steps is as follows:

[0032] (1.1) Waste silkworm silk was boiled in a 0.25 wt.% sodium carbonate aqueous solution at a bath ratio of 1:400 for 25 min, and stirred appropriately to ensure complete degumming. The degummed waste silkworm silk was placed in a 9.3 mol / L lithium bromide aqueous solution and dissolved at 60℃ at a mass ratio of 1:10. The solution was then dialyzed, centrifuged, purified, and concentrated to obtain a 20 wt.% silk fibroin aqueous solution.

[0033] (1.2) Cut the degummed waste silk fibers into short fibers of 5 mm in length, soak them in deionized water at a mass ratio of 1:100, mechanically grind them for 30 to 90 minutes, and then filter the silk fibroin slurry through a 100 to 500 mesh filter, centrifuge, and filter a second time to finally obtain a silk fibroin nanofiber aqueous solution with a concentration of 1 wt.%, wherein the length distribution range of the silk fibroin nanofiber is 10 to 150 μm and the diameter distribution range is 20 to 250 nm.

[0034] (1.3) Silk fibroin nanofibers were added to a silk fibroin aqueous solution at a dosage of 0.1–0.4 wt.%, and ultrasonically treated to ensure uniform dispersion. The ultrasonic treatment time was 20 min, the temperature was 5 °C, and the power was 120 W. A 20 wt.% polyvinyl alcohol aqueous solution was added to the ultrasonicated solution, with a polyvinyl alcohol to silk fibroin mass ratio of 1:1. The solution was stirred evenly to obtain a silk fibroin nanofiber / silk fibroin / polyvinyl alcohol composite aqueous solution. The silk fibroin nanofiber / silk fibroin / polyvinyl alcohol composite fiber was then prepared by dry-jet wet spinning. The solution feed rate was 2.8 ml / h, the needle inner diameter used for extrusion was 0.21 mm, the air section distance was 2 cm, the coagulation bath length was 90 cm, and the winding speed of the winding device was 92.3 m / h.

[0035] (2) Using deionized water as a solvent, prepare an ascorbic acid solution with a concentration of 1 wt.%. Weigh different masses of chitosan powder (chitosan viscosity ≥400 mPa·s) and dissolve them in the ascorbic acid solution to prepare a chitosan solution with a concentration of 0.5–3 wt.%. Fix both ends of the drawn fiber and completely immerse it in the chitosan solution for 1–5 minutes, repeating the immersion 1–5 times. Remove the immersed fiber and place it in a vacuum oven to dry at 60°C for 3 minutes.

[0036] In this step, different masses of chitosan powder are weighed because the concentration of the prepared chitosan solution is between 0.5% and 3 wt.%, and different concentrations correspond to different masses of chitosan powder. Chitosan solutions of different concentrations all exhibit good antibacterial effects, and the width of the inhibition zone increases with increasing chitosan concentration. The lowest concentration, 0.5 wt.%, of chitosan solution achieves the best antibacterial effect.

[0037] The silk fibroin-based ultrafine monofilament sutures prepared by the above method have a smooth surface, uniform structure, diameter of 36.6–42.9 μm, and breaking strength of 0.25–0.31 N, meeting the requirements of No. 9-0 sutures in the national standard YY0167-2020 Non-absorbable Surgical Sutures. They also have good antibacterial, anti-inflammatory, and healing-promoting functions.

[0038] To make the above-mentioned objects, features, and advantages of the present invention more apparent and understandable, the technical solutions of the present invention are further described below with reference to specific embodiments. However, the present invention is not limited to the listed embodiments, but should also include any other known modifications within the scope of the claims of the present invention.

[0039] The term "an embodiment" or "embodiment" as used herein refers to a specific feature, structure, or characteristic that may be included in at least one implementation of the invention. The phrase "in one embodiment" appearing in different places throughout this specification does not necessarily refer to the same embodiment, nor is it a single or selective embodiment that is mutually exclusive with other embodiments.

[0040] Example 1

[0041] The following examples illustrate a method for preparing a silk fibroin-based ultrafine monofilament suture, with the specific steps as follows:

[0042] (1) The nascent composite fibers of silk fibroin / polyvinyl alcohol / silk nanofibers are unwound from the winding roller and drawn into a 50 wt.% ethanol solution to soften them. After 30 seconds of immersion, they are drawn out of the bath and guided into the drafting device via a yarn guide device. Drafting then occurs between two rollers in the drafting device. Finally, guided by a reciprocating yarn guide device, the fibers are evenly wound onto a collecting device. The fiber unwinding speed and final collection speed are adjusted to achieve a draft ratio of 150%. (See also...) Figure 1 , Figure 1 This is a diagram showing the distribution changes of internal silk fibroin nanofibers before and after stretching treatment in Example 1 of the preparation method of silk fibroin-based ultrafine monofilament sutures according to the present invention. Figure 1 As can be seen, before the stretching treatment, the fibrils inside the fiber are unevenly dispersed, entangled, and randomly oriented. After the stretching treatment, the fibrils inside the fiber are evenly dispersed, regularly arranged, and neatly oriented. The fiber crystallinity increases, the strength and toughness increase, and the overall mechanical properties of the fiber are enhanced.

[0043] (2) Using deionized water as a solvent, prepare an ascorbic acid solution with a concentration of 1 wt.%. Weigh different masses of chitosan powder (chitosan viscosity ≥400 mPa·s) and dissolve them in the ascorbic acid solution to prepare a chitosan solution with a concentration of 0.5 wt.%. Fix both ends of the stretched fiber and completely immerse it in the chitosan solution for 1 min, repeating the immersion process 3 times. Remove the immersed fiber and place it in a vacuum oven to dry at 60℃ for 3 min.

[0044] The silk fibroin-based ultrafine monofilament suture prepared using the above-described method and process parameters has a diameter of 39.4 μm and a breaking strength of 0.31 N. Please refer to Table 1, which compares the performance of sutures prepared in Example 1 with those prepared using other related patents.

[0045] Table 1:

[0046]

[0047] As shown in Table 1, the suture obtained in Example 1 possesses numerous advantages, including being ultra-fine, antibacterial, biocompatible, and biodegradable. Please refer to... Figure 2 , Figure 2 The images show the surface morphology of the silk fibroin-based ultrafine monofilament suture prepared in Example 1 of the present invention, before and after coating treatment. Figure 2 As can be seen, uncoated sutures have a rough surface, resulting in greater friction with skin tissue during suturing, and bacteria can easily hide in the grooves. Coated sutures, on the other hand, have a smooth surface, resulting in less frictional resistance when penetrating tissue and less pain. Please refer to [link to relevant documentation]. Figure 3 , Figure 3 The image shows the antibacterial effect of the silk fibroin-based ultrafine monofilament suture prepared in Example 1 of the preparation method of the silk fibroin-based ultrafine monofilament suture according to the present invention against Escherichia coli and Staphylococcus aureus. Figure 3 As can be seen, the inhibition zone width against *Escherichia coli* in Example 1 was 0.64 mm, and the inhibition zone width against *Staphylococcus aureus* was 0.87 mm, indicating that the suture has good antibacterial activity. Please refer to [link / reference]. Figure 4 , Figure 4 This image shows the in vitro degradation of the silk fibroin-based ultrafine monofilament suture prepared in Example 1 of the preparation method of the silk fibroin-based ultrafine monofilament suture according to the present invention in PBS simulated body fluid. Figure 4 As can be seen, with increasing soaking time, the chitosan on the surface of the suture is first dissolved and detached, followed by the gradual degradation of the internal silk fibroin-based microfibers. When the soaking time was 30 days, the weight loss rate of the suture reached 43.09%. Please refer to [link / reference]. Figure 5 , Figure 5 The image shows the application of the silk fibroin-based ultrafine monofilament suture prepared in Example 1 of the present invention to mouse epidermal suture. Figure 5 As can be seen, the sutures can firmly fix the skin tissue during the suturing process and prevent the wound from opening; 5 days after suturing, the wound has recovered to a large extent without wound infection or tissue inflammation; 10 days after suturing, the wound is almost completely healed with no obvious needle marks; 15 days after suturing, the wound is completely healed without leaving any obvious scars, indicating that the sutures have a good effect on promoting wound healing and reducing scar hyperplasia.

[0048] Example 2

[0049] The following examples illustrate a method for preparing a silk fibroin-based ultrafine monofilament suture, with the specific steps as follows:

[0050] (1) The silk fibroin / polyvinyl alcohol / silk nanofiber nascent composite fiber is unwound from the winding roller and drawn into a 50wt.% ethanol solution to moisten and soften it. After 40s of immersion, it is drawn out of the bath and enters the drawing device through the yarn guiding device. It is drawn between the two rollers of the drawing device and finally evenly wound onto the collecting device under the guidance of the reciprocating yarn guiding device. The fiber unwinding speed and the final collecting speed are adjusted to make the drawing ratio 130%.

[0051] (2) Using deionized water as a solvent, prepare an ascorbic acid solution with a concentration of 1 wt.%. Weigh different masses of chitosan powder (chitosan viscosity ≥400 mPa·s) and dissolve them in the ascorbic acid solution to prepare a chitosan solution with a concentration of 2 wt.%. Fix both ends of the stretched fiber and completely immerse it in the chitosan solution for 3 minutes. Repeat the immersion once. Remove the immersed fiber and place it in a vacuum oven to dry at 60°C for 3 minutes.

[0052] The antibacterial silk fibroin-based ultrafine monofilament suture prepared by the above preparation method and process parameters has a diameter of 42.9 μm and a breaking strength of 0.25 N.

[0053] Example 3

[0054] The following examples illustrate a method for preparing a silk fibroin-based ultrafine monofilament suture, with the specific steps as follows:

[0055] (1) The nascent composite fiber of silk fibroin / polyvinyl alcohol / silk nanofiber is unwound from the winding roller and drawn into a 50wt.% ethanol solution to moisten and soften it. After 50s of immersion, it is drawn out of the bath and enters the drawing device through the yarn guiding device. It is drawn between the two rollers of the drawing device and finally evenly wound onto the collecting device under the guidance of the reciprocating yarn guiding device. The fiber unwinding speed and the final collecting speed are adjusted to make the drawing ratio 200%.

[0056] (2) Using deionized water as a solvent, prepare an ascorbic acid solution with a concentration of 1 wt.%. Weigh different masses of chitosan powder (chitosan viscosity ≥400 mPa·s) and dissolve them in the ascorbic acid solution to prepare a chitosan solution with a concentration of 1 wt.%. Fix both ends of the drawn fiber and completely immerse it in the chitosan solution for 5 minutes. Repeat the immersion 5 times. Remove the immersed fiber and place it in a vacuum oven to dry at 60℃ for 3 minutes.

[0057] The antibacterial silk fibroin-based ultrafine monofilament suture prepared by the above preparation method and process parameters has a diameter of 36.6 μm and a breaking strength of 0.28 N.

[0058] Example 4

[0059] The following examples illustrate a method for preparing a silk fibroin-based ultrafine monofilament suture, with the specific steps as follows:

[0060] (1) The silk fibroin / polyvinyl alcohol / silk nanofiber nascent composite fiber is unwound from the winding roller and drawn into a 50wt.% ethanol solution to moisten and soften it. After 60s of immersion, it is drawn out of the bath and enters the drawing device through the yarn guiding device. It is drawn between the two rollers of the drawing device and finally evenly wound onto the collecting device under the guidance of the reciprocating yarn guiding device. The fiber unwinding speed and the final collecting speed are adjusted to make the drawing ratio 180%.

[0061] (2) Using deionized water as a solvent, prepare an ascorbic acid solution with a concentration of 1 wt.%. Weigh different masses of chitosan powder (chitosan viscosity ≥400 mPa·s) and dissolve them in the ascorbic acid solution to prepare a chitosan solution with a concentration of 3 wt.%. Fix both ends of the drawn fiber and completely immerse it in the chitosan solution for 3 minutes. Repeat the immersion process 3 times. Remove the immersed fiber and place it in a vacuum oven to dry at 60°C for 3 minutes.

[0062] The antibacterial silk fibroin-based ultrafine monofilament suture prepared by the above preparation method and process parameters has a diameter of 39.9 μm and a breaking strength of 0.28 N.

[0063] In summary, the method for preparing a silk fibroin-based ultrafine monofilament suture of the present invention involves stretching a silk fibroin / polyvinyl alcohol / silk fibroin nanofiber composite fiber to obtain ultrafine fibers, and then coating the surface of the ultrafine fibers with chitosan to prepare the ultrafine monofilament suture. This suture has a smooth surface, uniform structure, a diameter of 36.6–42.9 μm, and a tensile strength of 0.25–0.31 N, meeting the strength requirements for suturing. It also exhibits good antibacterial properties, effectively inhibiting bacterial growth and reducing wound infection. Furthermore, the silk fibroin, polyvinyl alcohol, and chitosan used in this suture all possess excellent biocompatibility, promoting wound healing and reducing scar hyperplasia, demonstrating significant application potential in the field of medical suture materials.

[0064] It should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and are not intended to limit it. Although the present invention has been described in detail with reference to preferred embodiments, those skilled in the art should understand that modifications or equivalent substitutions can be made to the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention, and all such modifications or substitutions should be covered within the scope of the claims of the present invention.

Claims

1. A method for preparing a silk fibroin-based ultrafine monofilament suture, characterized by, Includes the following steps: (1) The nascent composite fiber of silk fibroin / polyvinyl alcohol / silk nanofiber is unwound from the winding roller and drawn into the bath liquid to moisten and soften it. Then it is drawn out of the bath liquid, enters the drawing device through the yarn guiding device, and is drawn between the two rollers of the drawing device. Finally, under the guidance of the reciprocating yarn guiding device, it is evenly wound onto the collecting device to obtain the drawn fiber. The preparation method of the nascent composite fiber of silk fibroin / polyvinyl alcohol / silk nanofiber includes the following steps: (1.1) Waste silkworm silk was boiled in a 0.25 wt.% sodium carbonate aqueous solution at a bath ratio of 1:400 for 25 minutes, and stirred appropriately to fully degummed the silkworm silk. The degummed waste silkworm silk was placed in a 9.3 mol / L lithium bromide aqueous solution and dissolved at 60 °C at a mass ratio of 1:

10. After dialysis, centrifugation, impurity removal and concentration, a 20 wt.% silk fibroin aqueous solution was obtained. (1.2) The degummed waste silk is cut into short fibers of 5 mm in length, soaked in deionized water at a mass ratio of 1:100, mechanically ground for 30 to 90 min, and then the silk fibroin slurry is filtered through a 100 to 500 mesh filter, centrifuged, and filtered a second time to finally obtain a silk fibroin nanofiber aqueous solution with a concentration of 1 wt.%. The silk fibroin nanofiber aqueous solution has a length distribution range of 10 to 150 μm and a diameter distribution range of 20 to 250 nm. (1.3) The silk fibroin nanofibers were added to the silk fibroin aqueous solution at an addition rate of 0.1–0.4 wt.%, and ultrasonically treated to ensure uniform dispersion. The ultrasonic treatment time was 20 min, the temperature was 5 ℃, and the power was 120 W. A 20 wt.% polyvinyl alcohol aqueous solution was added to the ultrasonicated solution. The mass ratio of polyvinyl alcohol to silk fibroin was 1:

1. After stirring evenly, a silk fibroin / polyvinyl alcohol / silk fibroin nanofiber composite aqueous solution was obtained. The nascent composite fiber of silk fibroin / polyvinyl alcohol / silk fibroin nanofibers was prepared by dry-jet wet spinning. The feed rate of the dry-jet wet spinning method was 2.8 ml / h, the inner diameter of the needle used for extrusion was 0.21 mm, the distance of the air section was 2 cm, the length of the coagulation bath was 90 cm, and the winding speed of the winding device was 92.3 m / h. When the silk fibroin / polyvinyl alcohol / silk fibroin nanofiber nascent composite fiber is uniformly wound onto the collecting device under the guidance of the reciprocating yarn guiding device, it is necessary to adjust the fiber unwinding speed and the final collecting speed to make the draw ratio 130~200%. (2) Using deionized water as a solvent, an ascorbic acid solution is prepared. Chitosan powder is weighed and dissolved in the ascorbic acid solution to prepare a chitosan solution. The two ends of the stretched fiber are fixed and completely immersed in the chitosan solution. The immersed fiber is taken out and placed in a vacuum oven to dry, thereby obtaining a silk fibroin-based ultrafine monofilament suture. The diameter of the silk fibroin-based ultrafine monofilament suture is 36.6–42.9 μm and the breaking strength is 0.25–0.31 N.

2. The method for preparing a silk fibroin-based ultrafine monofilament suture according to claim 1, characterized in that: In step (1), the bath liquid is an ethanol solution with a concentration of 50 wt.% and the soaking time is 30~60s.

3. The method for preparing a silk fibroin-based ultrafine monofilament suture according to claim 1, characterized in that: In step (2), the concentration of the ascorbic acid solution is 1 wt.%.

4. The method for preparing a silk fibroin-based ultrafine monofilament suture according to claim 1, characterized in that: In step (2), the chitosan viscosity of the chitosan powder is ≥400 mPa·s.

5. The method for preparing a silk fibroin-based ultrafine monofilament suture according to claim 1, characterized in that: In step (2), the concentration of the chitosan solution is 0.5–3 wt.%.

6. The method for preparing a silk fibroin-based ultrafine monofilament suture according to claim 1, characterized in that: In step (2), the soaking time is 1 to 5 minutes and the number of soakings is 1 to 5 times.

7. The method for preparing a silk fibroin-based ultrafine monofilament suture according to claim 1, characterized in that: In step (2), the drying temperature is 60°C and the time is 3 min.

Citation Information

Patent Citations

  • Surgical seam of yamamai silk and preparation thereof

    CN101244288A

  • Long-acting controlled-release antibacterial real silk woven type surgical suture and preparing method thereof

    CN103816564A

  • Barbed silk suture line and preparation method thereof

    CN113197705A

  • Flexible silk fibroin / polyvinyl alcohol composite fiber and preparation method thereof

    CN113005560A

  • Natural long-acting antibacterial and anti-inflammatory silk suture line and production method thereof

    CN114059350A